Increased ACE2, sRAGE, and immune activation, but lowered calcium and magnesium in COVID-19
AuthorsHussein K Al-Hakeim,, Hawraa Kadhem Al-Jassas, Gerwyn Morris, Michael Maes
JournalRecent Advances in Inflammation & Allergy Drug Discovery
AbstractBackground
The characterization of new biomarkers that could help externally validate the diagnosis of COVID-19 and optimize treatments is extremely important. Many studies have established changes in immune-inflammatory and antibody levels, but few studies measured the soluble receptor for the advanced glycation end product (sRAGE), angiotensin-converting enzyme 2 (ACE2), calcium, and magnesium in COVID-19.
Increased angiotensin-converting enzyme 2, sRAGE and immune activation, but lowered calcium and magnesium in COVID-19: association with chest CT abnormalities and lowered …
AuthorsHussein Kadhem Al-Hakeim, Hawraa Kadhem Al-Jassas, Gerwyn Morris, Michael Maes
JournalmedRxiv
AbstractBackground
The characterization of new biomarkers of COVID-19 is extremely important. Few studies measured the soluble receptor for advanced glycation end product (sRAGE), angiotensin-converting enzyme 2 (ACE2), calcium and magnesium in COVID-19.
Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: A nomothetic network approach
AuthorsHawraa Kadhem Al-Jassas, Hussein Kadhem Al-Hakeim 2, Michael Maes 3
JournalElsevier Public Health emergency collection
AbstractCOVID-19 is associated with neuropsychiatric symptoms including increased depressive, anxiety and chronic fatigue-syndrome (CFS)-like and physiosomatic symptoms.
Aims